Cambridge v COVID-19

Cambridge is working hard to ensure that the full strength of the University’s research powers and resources are used in the global fight against COVID-19.

Cambridge v COVID-19

Dear World,
It’s on.
Cambridge v COVID-19.
And it’s a fight we’ll win.
Yours, Cambridge

We’ve been challenged to a fight none of us were expecting, and all over the world, society is being pummelled.

Cambridge is being hit hard too, but we’re fighting back in three arenas:

The Virus
We must find the means to better diagnose, treat and stop the virus causing this pandemic.

Student Support
We must assist our students, whose lives and studies have been upended in so many ways, to stay strong and stay the distance.

The Equipment 
We must ensure high-grade PPE equipment for frontline medical staff and researchers across the UK.

You can help us to knock out COVID-19 and alleviate the bruises it has imparted on our world. A donation of any size to any of the areas below will help advance our work and will have a real and immediate impact.

Together we can defeat COVID-19

Related stories

Philanthropic giving is at the heart of the success of the Collegiate University, enabling us to make discoveries that change the world and to ensure that our students receive an unrivalled education. Cambridge owes its world-leading excellence in research and teaching to the generosity of its supporters. Our history is synonymous with a history of far-sighted benefaction, and the same is as true today as it has ever been.

Decorative
Philanthropic impact story
The COVID-19 pandemic will have a “profound” impact on philanthropy through forging more active collaboration and ensuring more equitable responses, Bill Gates said in an interview with Badr Jafar (Churchill College, 1997), founding patron of the Centre for Strategic Philanthropy at Cambridge Judge Business School.
decorative
Philanthropic impact story
A Cambridge-developed vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK in late autumn or early next year, thanks to a £1.9million award from the UK government.
decorative
Philanthropic impact story
The University of Cambridge and Royal Papworth Hospital have secured £1.5million of funding as part of the national effort by UK immunologists to understand immune responses to SARS-CoV-2, the coronavirus that causes COVID-19.